Provided by Tiger Trade Technology Pte. Ltd.

Skye Bioscience Inc.

1.99
-0.0500-2.45%
Volume:53.90K
Turnover:104.93K
Market Cap:8.74M
PE:-0.19
High:2.04
Open:2.04
Low:1.88
Close:2.04
52wk High:39.92
52wk Low:1.64
Shares:4.39M
Float Shares:2.87M
Volume Ratio:0.47
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.2399
EPS(LYR):-11.2801
ROE:-233.87%
ROA:-95.06%
PB:-17.57
PE(LYR):-0.18

Loading ...

Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report